{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:54:41Z","timestamp":1776329681261,"version":"3.50.1"},"reference-count":19,"publisher":"Baskent University","issue":"Suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.6002\/ect.mesot2018.p102","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T01:48:43Z","timestamp":1550627323000},"page":"239-241","source":"Crossref","is-referenced-by-count":15,"title":["Intra-Arterial Injection of Autologous Bone Marrow-Derived Mononuclear Cells in Ischemic Stroke Patients"],"prefix":"10.6002","volume":"17","author":[{"name":"the Alyermouk Teaching Hospital, Baghdad, Iraq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Majeed Alwan","family":"Hammadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"and the Packy Hospital, Erbil, Iraq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fizel","family":"Alhimyari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4021","reference":[{"issue":"1","key":"ref0","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jocn.2008.05.006","article-title":"Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke","volume":"16","author":"Dharmasaroja","year":"2009","unstructured":"1.\tDharmasaroja P. Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke. J Clin Neurosci. 2009;16(1):12-20.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"ref1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/exnr.2001.7853","article-title":"Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats","volume":"174","author":"Zhao","year":"2002","unstructured":"2.\tZhao LR, Duan WM, Reyes M, et al. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol. 2002;174(1):11-20.","journal-title":"Exp Neurol"},{"issue":"8","key":"ref2","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1586\/14737175.8.8.1193","article-title":"Cell-based therapy in ischemic stroke","volume":"8","author":"DC","year":"2008","unstructured":"3.\tHess DC, Borlongan CV. Cell-based therapy in ischemic stroke. Expert Rev Neurother. 2008;8(8):1193-1201.","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"ref3","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"Lee","year":"2010","unstructured":"4.\tLee JS, Hong JM, Moon GJ, et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells. 2010;28(6):1099-1106.","journal-title":"Stem Cells"},{"issue":"3","key":"ref4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.pneurobio.2008.04.005","article-title":"Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke","volume":"85","author":"Hara","year":"2008","unstructured":"5.\tHara K, Yasuhara T, Maki M, et al. Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke. Prog Neurobiol. 2008;85(3):318-334.","journal-title":"Prog Neurobiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2184.2008.00486.x","article-title":"Stem cells and neurological diseases.","volume":"41","author":"Hess","year":"2008","unstructured":"6.\tHess DC, Borlongan CV. Stem cells and neurological diseases. Cell Prolif. 2008;41 Suppl 1:94-114.","journal-title":"Cell Prolif","ISSN":"https:\/\/id.crossref.org\/issn\/0960-7722","issn-type":"print"},{"issue":"13","key":"ref6","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1523\/JNEUROSCI.5165-05.2006","article-title":"Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats","volume":"26","author":"Shyu","year":"2006","unstructured":"7.\tShyu WC, Lin SZ, Chiang MF, Su CY, Li H. Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. J Neurosci. 2006;26(13):3444-3453.","journal-title":"J Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.brainres.2008.06.123","article-title":"Mesenchymal stem cells transplantation could be beneficial for treatment of experimental ischemic stroke in rats","volume":"1233","author":"Pavlichenko","year":"2008","unstructured":"8.\tPavlichenko N, Sokolova I, Vijde S, et al. Mesenchymal stem cells transplantation could be beneficial for treatment of experimental ischemic stroke in rats. Brain Res. 2008;1233:203-213.","journal-title":"Brain Res"},{"issue":"6","key":"ref8","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/01.RES.0000063425.51108.8D","article-title":"Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats","volume":"92","author":"Chen","year":"2003","unstructured":"9.\tChen J, Zhang ZG, Li Y, et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res. 2003;92(6):692-699.","journal-title":"Circ Res"},{"issue":"1","key":"ref9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/sj.jcbfm.9600311","article-title":"Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke","volume":"27","author":"Shen","year":"2007","unstructured":"10.\tShen LH, Li Y, Chen J, et al. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab. 2007;27(1):6-13.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"ref10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/scd.2008.0253","article-title":"Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect","volume":"18","author":"Fischer","year":"2009","unstructured":"11.\tFischer UM, Harting MT, Jimenez F, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2009;18(5):683-692.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"ref11","first-page":"124","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"15","year":"2004","unstructured":"12.\tWorld Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Int Bioethique. 2004;15(1):124-129.","journal-title":"J Int Bioethique","ISSN":"https:\/\/id.crossref.org\/issn\/1145-0762","issn-type":"print"},{"issue":"11","key":"ref12","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1161\/01.STR.25.11.2215","article-title":"The European Stroke Scale","volume":"25","author":"Hantson","year":"1994","unstructured":"13.\tHantson L, De Weerdt W, De Keyser J, et al. The European Stroke Scale. Stroke. 1994;25(11):2215-2219.","journal-title":"Stroke"},{"issue":"1","key":"ref13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ana.22458","article-title":"Intravenous autologous bone marrow mononuclear cells for ischemic stroke","volume":"70","author":"Savitz","year":"2011","unstructured":"14.\tSavitz SI, Misra V, Kasam M, et al. Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol. 2011;70(1):59-69.","journal-title":"Ann Neurol"},{"issue":"2","key":"ref14","first-page":"221","article-title":"Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study.","volume":"136","author":"Prasad","year":"2012","unstructured":"15.\tPrasad K, Mohanty S, Bhatia R, et al. Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study. Indian J Med Res. 2012;136(2):221-228.","journal-title":"Indian J Med Res","ISSN":"https:\/\/id.crossref.org\/issn\/0971-5916","issn-type":"print"},{"issue":"12","key":"ref15","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1161\/STROKEAHA.114.007028","article-title":"Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial","volume":"45","author":"Prasad","year":"2014","unstructured":"16.\tPrasad K, Sharma A, Garg A, et al. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial. Stroke. 2014;45(12):3618-3624.","journal-title":"Stroke"},{"issue":"12","key":"ref16","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1161\/STROKEAHA.111.000821","article-title":"Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke","volume":"44","author":"Yang","year":"2013","unstructured":"17.\tYang B, Migliati E, Parsha K, et al. Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke. Stroke. 2013;44(12):3463-3472.","journal-title":"Stroke"},{"issue":"8","key":"ref17","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1161\/STROKEAHA.112.659409","article-title":"Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial","volume":"43","author":"Moniche","year":"2012","unstructured":"18.\tMoniche F, Gonzalez A, Gonzalez-Marcos JR, et al. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. Stroke. 2012;43(8):2242-2244.","journal-title":"Stroke"},{"issue":"2","key":"ref18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2217\/rme.13.2","article-title":"Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients","volume":"8","author":"Rosado-de-Castro","year":"2013","unstructured":"19.\tRosado-de-Castro PH, Schmidt Fda R, Battistella V, et al. Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients. Regen Med. 2013;8(2):145-155.","journal-title":"Regen Med"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T05:43:05Z","timestamp":1550641385000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/forms\/ectrxcontentshow.php?doi_id=10.6002\/ect.MESOT2018.P102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":19,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2019,1]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.mesot2018.p102","relation":{},"ISSN":["1304-0855"],"issn-type":[{"value":"1304-0855","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}